Literature DB >> 35678912

Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.

Wen-Dan Chen1, Xin Zhang1, Ya-Ping Zhang1, Cong-Bo Yue1, Yan-Lei Wang2, Hong-Wei Pan1, Yan-Li Zhang3, Hui Liu1, Yi Zhang4.   

Abstract

OBJECTIVE: Increasing evidence has indicated that there is a correlation between Fusobacterium nucleatum (F. nucleatum) abundance and poor prognosis of colorectal cancer (CRC). Furthermore, tumor metastasis plays a decisive role in the prognosis of CRC patients. Therefore, it was hypothesized that the abundance of F. nucleatum in CRC tissues affects the tumor metastasis.
METHODS: In the present study, F. nucleatum DNA obtained from 141 resected CRC samples was quantified by qPCR to determine whether there were differences in F. nucleatum abundance between groups with and without CRC metastasis.
RESULTS: The results revealed that F. nucleatum was more abundant in CRC patients with metastasis, and CRC tissues enriched with F. nucleatum had a higher risk of lymph node metastasis and distant metastasis. The receiver operating characteristic curve indicated that F. nucleatum in CRC tissues could be used as an indicator for CRC metastasis, to some extent. Furthermore, the in vitro experiments (electron microscopy, and migration and invasion trials) revealed that F. nucleatum was a highly invasive bacterial strain, and could significantly enhance the invasion and migration capacity of SW480 and SW620 cells. In addition, a meta-analysis comprehensively indicated a slight correlation between F. nucleatum abundance and advanced CRC stage (RR=1.17, 95% CI: 1.00-1.37, P=0.04, random effect).
CONCLUSION: There is a correlation between F. nucleatum abundance and CRC metastasis, and F. nucleatum may serve as a metastasis biomarker for CRC patients.
© 2022. Huazhong University of Science and Technology.

Entities:  

Keywords:  Fusobacterium nucleatum; colorectal cancer; metastasis

Mesh:

Year:  2022        PMID: 35678912     DOI: 10.1007/s11596-022-2597-1

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  45 in total

Review 1.  Chemotherapy of advanced cancer of the colon and rectum.

Authors:  H W Bruckner; B T Motwani
Journal:  Semin Oncol       Date:  1991-10       Impact factor: 4.929

2.  Colorectal cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ann Goding Sauer; Stacey A Fedewa; Lynn F Butterly; Joseph C Anderson; Andrea Cercek; Robert A Smith; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-03-05       Impact factor: 508.702

Review 3.  Fusobacterium nucleatum: a commensal-turned pathogen.

Authors:  Yiping W Han
Journal:  Curr Opin Microbiol       Date:  2015-01-08       Impact factor: 7.934

Review 4.  Host-microbiota maladaptation in colorectal cancer.

Authors:  Alina Janney; Fiona Powrie; Elizabeth H Mann
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  EPMA position paper in cancer: current overview and future perspectives.

Authors:  Godfrey Grech; Xianquan Zhan; Byong Chul Yoo; Rostyslav Bubnov; Suzanne Hagan; Romano Danesi; Giorgio Vittadini; Dominic M Desiderio
Journal:  EPMA J       Date:  2015-04-15       Impact factor: 6.543

7.  Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition.

Authors:  Kai Zhang; Tao Peng; Qingying Yan; Leitao Sun; Haojun Miao; Li Yuan; Yuxin Hong; Mengmeng Zhou; Kaibo Guo; Leyin Zhang; Jing Fang; Minhe Shen; Shanming Ruan
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629

Review 8.  Fusobacterium and Colorectal Cancer.

Authors:  Ziwei Zhou; Jiewen Chen; Herui Yao; Hai Hu
Journal:  Front Oncol       Date:  2018-10-15       Impact factor: 6.244

9.  Serum enterolactone concentrations are low in colon but not in rectal cancer patients.

Authors:  Anne Tuomisto; Natalja P Nørskov; Päivi Sirniö; Juha P Väyrynen; Shivaprakash J Mutt; Kai Klintrup; Jyrki Mäkelä; Knud Erik Bach Knudsen; Markus J Mäkinen; Karl-Heinz Herzig
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

10.  Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia.

Authors:  Bo-Young Hong; Takayasu Ideta; Bruno S Lemos; Yuichi Igarashi; Yuliana Tan; Michael DiSiena; Allen Mo; John W Birk; Faripour Forouhar; Thomas J Devers; George M Weinstock; Daniel W Rosenberg
Journal:  NPJ Precis Oncol       Date:  2019-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.